1] Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China [2] Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China.
1] Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China [2] Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China [3] Guangzhou Branch of the Supercomputing Center of Chinese Academy of Sciences, Guangzhou 510530, China.
Nat Cell Biol. 2015 Jul;17(7):856-67. doi: 10.1038/ncb3193. Epub 2015 Jun 22.
Oncogenic transcription factors are known to mediate the conversion of somatic cells to tumour or induced pluripotent stem cells (iPSCs). Here we report c-Jun as a barrier for iPSC formation. c-Jun is expressed by and required for the proliferation of mouse embryonic fibroblasts (MEFs), but not mouse embryonic stem cells (mESCs). Consistently, c-Jun is induced during mESC differentiation, drives mESCs towards the endoderm lineage and completely blocks the generation of iPSCs from MEFs. Mechanistically, c-Jun activates mesenchymal-related genes, broadly suppresses the pluripotent ones, and derails the obligatory mesenchymal to epithelial transition during reprogramming. Furthermore, inhibition of c-Jun by shRNA, dominant-negative c-Jun or Jdp2 enhances reprogramming and replaces Oct4 among the Yamanaka factors. Finally, Jdp2 anchors 5 non-Yamanaka factors (Id1, Jhdm1b, Lrh1, Sall4 and Glis1) to reprogram MEFs into iPSCs. Our studies reveal c-Jun as a guardian of somatic cell fate and its suppression opens the gate to pluripotency.
致癌转录因子已知可介导体细胞向肿瘤或诱导多能干细胞(iPS 细胞)的转化。在这里,我们报告 c-Jun 是 iPSC 形成的障碍。c-Jun 由小鼠胚胎成纤维细胞(MEF)表达并需要其增殖,但不是小鼠胚胎干细胞(mESC)。一致地,c-Jun 在 mESC 分化过程中被诱导,驱动 mESC 向内胚层谱系,并完全阻止 MEF 产生 iPSC。从机制上讲,c-Jun 激活间充质相关基因,广泛抑制多能基因,并在重编程过程中破坏必需的间充质到上皮过渡。此外,通过 shRNA、显性负性 c-Jun 或 Jdp2 抑制 c-Jun 可增强重编程,并在 Yamanaka 因子中取代 Oct4。最后,Jdp2 将 5 种非 Yamanaka 因子(Id1、Jhdm1b、Lrh1、Sall4 和 Glis1)锚定到 MEF 中,将其重编程为 iPSC。我们的研究揭示了 c-Jun 作为体细胞命运的守护者,其抑制为多能性打开了大门。